Literatuurlijst Kinderwens en zwangerschap

• Akdeniz, F., Vahip, S., Pirildar, S., Vahip, I., Doganer, I., & Bulut, I. (2003). Risk factors associated with childbearing-related episodes in women with bipolar disorder. Psychopathology, 36, 234-238.
• Anderson, C.A., & Hammen, C.L. (1993). Psychosocial outcomes of children of unipolar depressed, bipolar, medically ill, and normal women: A longitudinal study. Journal of Consulting and Clinical Psychology, 61, 448-454.
• Austin, M.P. (1992). Puerperal affective psychosis: is there a case for lithium pro phylaxis? British Journal of Psychiatry, 161, 692-694.
• Bergink, V., Bouvy, P.F., Vervoort, J.S., Koorengevel, K.M., Steegers, E.A., & Kushner, S.A. (2012). Prevention of postpartum psychosis and mania in women at high risk. American Journal of Psychiatry, 169, 609-615.
• Blackmore, E.R., Jones, I., Doshi, M., Haque, S., Holder, R., & Brockington, I. (2006). Obstetric variables associated with bipolar affective puerperal psychosis. British Journal of Psychiatry, 188, 32-36.
• Blehar, M.C., DePaulo, J.R.J., Gershon, E.S., Reich, T., Simpson, S.G., & Nurnberger, J.I.J. (1998). Women with bipolar disorder: Findings from the NIMH Genetics Initiative sample. Psychopharmacology Bulletin, 34, 239-243.
• Bodén, R., Lundgren, M., Brandt, L., Reutfors, J., Andersen, M., & Kieler, H. (2012). Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study. BMJ, 345, e7085.
• Bulbul, F., Copoglu U.S., Alpak, G., Unal, A., Demir, B., Tastan, M.F., e.a. (2013). Electroconvulsive therapy in pregnant patients. General Hospital Psychiatry, 35, 636-639.
• Campbell, E., Kennedy, F., Russell, A., Smithson, W.H., Parsons, L., Morrison, P.J., e.a. (2014). Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. Journal of Neurology, Neurosurgery and Psychiatry, 85, 1029-1034.
• CBG (2014). Aangescherpte waarschuwing: Valproaat (waaronder Depakine, Propymal, Orfiril) verhoogt de kans op afwijkingen foetus [internetpagina]. Utrecht: College ter Beoordeling van Geneesmiddelen. Raadpleegbaar via: http://www.cbg-meb.nl/CBG/nl/humane-geneesmiddelen/actueel/141222_ DHPC_valproaat/default.htm.
• Cohen, L.S., Friedman, J.M., Jefferson, J.W., Johnson, E.M., & Weiner, M.L. (1994). A reevaluation of risk of in utero exposure to lithium. Journal of American Medical Association, 271, 146-150.
• Cohen, L.S., Sichel, D.A., Robertson, L.M., Heckscher, E., & Rosenbaum J.F. (1995). Postpartum prophylaxis for women with bipolar disorder. American Journal of Psychiatry, 152, 1641-1645.
• Craddock, N., & Jones, I. (2001). Molecular genetics of bipolar disorder [Review]. British Journal of Psychiatry, 41, s128-s33.
• Deligiannidis, K.M., Byatt, N., & Freeman, M.P. (2014). Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring. Journal of  Clinical Psychopharmacology, 34, 244-255.
• Diav-Citrin, O., Shechtman, S., Tahover, E., Finkel-Pekarsky, V., Arnon, J., Kennedy, D., e.a. (2014). Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. American Journal of Psychiatry, 171, 785-794.
• Freeman, M.P., Smith, K.W., Freeman, S.A., McElroy, S.L., Kmetz, G.E., Wright, R., e.a. (2002). The impact of reproductive events on the course of bipolar disorder in women. Journal of Clinical Psychiatry, 63, 284-287.
• Galbally, M., Roberts, M., & Buist, A. (2010). Mood stabilizers in pregnancy: a systematic review. Australian and New Zealand Journal of Psychiatry, 44, 967-977.
• Geddes, J.R., & Miklowitz, D.J. (2013). Treatment of bipolar disorder. Lancet, 381, 1672-1682.
• Gent, E.M. van, & Verhoeven W.M. (1992). Bipolar illness, lithium prophylaxis, and pregnancy. PharmacoPsychiatry, 25, 187-191.
• Gentile, S. (2008). Infant safety with antipsychotic therapy in breast-feeding: a systematic review. Journal of Clinical Psychiatry, 69, 666-673.
• Gentile S. (2012). Lithium in pregnancy: the need to treat, the duty to ensure safety. Expert Opinion in Drug Safety, 11, 425-437.
• Goedhart, G., Snijders, A.C., Hesselink, A.E., Poppel, M.N. van, Bonsel, G.J., & Vrijkotte, T.G. (2010). Maternal depressive symptoms in relation to perinatal mortality and morbidity: results from a large multiethnic cohort study. Psychosomatic Medicine, 72, 769-776.
• Grof, P., Robbins, W., Alda, M., Berghoefer, A., Vojtechovsky, M., Nilsson, A., e.a. (2000). Protective effect of pregnancy in women with lithium-responsive bipolar disorder. Journal of Affective Disorders, 61, 31-39.
• Harlow, B.L., Vitonis, A.F., Sparen, P., Cnattingius, S., Joffe, H., & Hultman, C.M. (2007). Incidence of hospitalization for postpartum psychotic and bipolar episodes in women with and without prior prepregnancy or prenatal psychiatric hospitalizations. Archives of General Psychiatry, 64, 42-48.
• Heffner, J.L., DelBello, M.P., Fleck, D.E., Adler, C.M., & Strakowski, S.M. (2012). Unplanned pregnancies in adolescents with bipolar disorder. American Journal of Psychiatry, 169, 1319.
• Kendell, R.E., Chalmers, J.C., & Platz, C. (1987). Epidemiology of puerperal psychoses. British Journal of Psychiatry, 150, 662-673.
• Kumar, R., Marks, M., Wieck, A., Hirst, D., Campbell, I., & Checkley, S. (1993). Neuroendocrine and psychosocial mechanisms in post-partum psychosis. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 17, 571-579.
• Lee, H.C., & Lin, H.C. (2010). Maternal bipolar disorder increased low birthweight and preterm births: A nationwide population-based study. Journal of Affective Disorders, 121, 100-105.
• McKnight, R.F., Adida, M., Budge, K., Stockton, S., Goodwin, G.M., & Geddes, J.R. (2012). Lithium toxicity profile: a systematic review and meta-analysis. Lancet, 379, 721-728.
• Mesman, E., Nolen, W.A., Reichart, C.G., Wals, M., & Hillegers, M.H. (2013). The Dutch bipolar offspring study: 12-year follow-up. American Journal of Psychiatry, 170, 542-549.
• Munk-Olsen, T., Laursen, T.M., Mendelson, T., Pedersen, C.B., Mors, O., & Mortensen, P.B. (2009). Risks and predictors of readmission for a mental disorder during the postpartum period. Archives of General Psychiatry, 66, 189-195.
• Munk-Olsen, T., Laursen, T.M., Meltzer-Brody, S., Mortensen, P.B., & Jones, I. (2012). Psychiatric disorders with postpartum onset: possible early manifestations of bipolar affective disorders. Archives of General Psychiatry, 69, 428-434.
• Nadebaum, C., Anderson, V., Vadja, F., Reutens, D., & Wood, A. (2012). Neurobehavioral Consequences of Prenatal Antiepileptic Drug exposure. Developmental NeuroPsychology, 37, 1-29.
• Newport, D.J., Stowe, Z.N., Viguera, A.C., Calamaras, M.R., Juric, S., Knight, B., e.a. (2008). Lamotrigine in bipolar disorder: efficacy during pregnancy. Bipolar Disorders, 10, 432-436.
• NVOG (2012). Richtlijn: SSRI-gebruik in de zwangerschap en tijdens de lactatie. Utrecht: Nederlandse Vereniging voor Obstetrie en Gynaecologie.
• Sharma, V. (2003). Role of sleep in the causation of puerperal psychosis. Medical Hypotheses, 61, 477-481.
• Sharma, V., & Pope, C.J. (2012). Pregnancy and bipolar disorder: a systematic review. Journal of Clinical Psychiatry, 73, 1447-1455.
• Sharma, V., Smith, A., & Mazmanian, D. (2006). Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder. Bipolar Disorders, 8, 400-404.
• Tomson, T., Battino, D., Bonizzoni, E., Craig, J., Lindhout, D., Sabers, A., e.a. (2011). Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Lancet Neurology, 10, 609-617.
• Viguera, A.C., Nonacs, R., Cohen, L.S., Tondo, L., Murray, A., & Baldessarini, R.J. (2000). Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. American Journal of Psychiatry, 157, 179-184.
• Viguera, A.C., Whitfield, T., Baldessarini, R.J., Newport, D.J., Stowe, Z., Reminick, A., e.a. (2007). Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. American Journal of Psychiatry, 164, 1817-1824.
• Viguera, A.C., Tondo, L., Koukopoulos, A.E., Reginaldi, D., Lepri, B., & Baldessarini, R.J. (2011). Episodes of mood disorders in 2,252 pregnancies and postpartum periods. American Journal of Psychiatry, 168, 1179-1185.
• Wisner, K.L., Hanusa, B.H., Peindl, K.S., & Perel, J.M. (2004). Prevention of postpartum episodes in women with bipolar disorder. Biological Psychiatry, 56, 592-596.
• Yonkers, K.A., Wisner, K.L., Stowe, Z., Leibenluft, E., Cohen, L., Miller, L., e.a. (2004). Management of bipolar disorder during pregnancy and the postpartum period. American Journal of Psychiatry, 161, 608-620.
• Yonkers, K.A., Vigod, S., & Ross, L.E. (2011). Diagnosis, pathophysiology, and management of mood disorders in pregnant and postpartum women. Obstetrics and Gynecology, 117, 961-977.